vs
Side-by-side financial comparison of FMC CORP (FMC) and ハンツマン (HUN), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.
ハンツマン is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× FMC CORP). ハンツマン runs the higher net margin — -158.8% vs -7.1%, a 151.8% gap on every dollar of revenue. On growth, ハンツマン posted the faster year-over-year revenue change (-6.7% vs -11.5%). FMC CORP produced more free cash flow last quarter ($631.1M vs $19.0M). Over the past eight quarters, FMC CORP's revenue compounded faster (8.6% CAGR vs -4.0%).
FMCコーポレーションはペンシルベニア州フィラデルフィアに本社を置く米国の化学製品製造企業です。1883年に殺虫剤メーカーとして創業した後、事業を多角化し、第二次世界大戦中は米国陸軍省向けに水陸両用装軌式上陸車両の設計・製造を請け負いました。現在では世界中に7,000人の従業員を擁しています。
ハンツマンコーポレーションは米国テキサス州ウッドランズに本社を置く多国籍化学メーカーで、消費者向け・産業向けにポリウレタン、高機能製品、接着剤などを製造・販売しています。BMW、GE、シェブロン、P&G、ユニリーバなどを主要顧客に持ち、25カ国以上に60を超える生産・研究開発・拠点を展開し、約7,000人の従業員を擁しています。
FMC vs HUN — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.4B |
| Net Profit | $-1.7B | $-96.0M |
| Gross Margin | 39.8% | 12.1% |
| Operating Margin | -130.8% | -4.4% |
| Net Margin | -158.8% | -7.1% |
| Revenue YoY | -11.5% | -6.7% |
| Net Profit YoY | -10457.1% | 31.9% |
| EPS (diluted) | $-13.77 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $542.2M | $1.5B | ||
| Q2 25 | $1.1B | $1.5B | ||
| Q1 25 | $791.4M | $1.4B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.1B | $1.5B | ||
| Q2 24 | $1.0B | $1.6B | ||
| Q1 24 | $918.0M | $1.5B |
| Q4 25 | $-1.7B | $-96.0M | ||
| Q3 25 | $-569.3M | $-25.0M | ||
| Q2 25 | $66.7M | $-158.0M | ||
| Q1 25 | $-15.5M | $-5.0M | ||
| Q4 24 | $-16.3M | $-141.0M | ||
| Q3 24 | $65.0M | $-33.0M | ||
| Q2 24 | $295.1M | $22.0M | ||
| Q1 24 | $-2.7M | $-37.0M |
| Q4 25 | 39.8% | 12.1% | ||
| Q3 25 | 23.8% | 14.0% | ||
| Q2 25 | 38.7% | 12.5% | ||
| Q1 25 | 40.0% | 14.3% | ||
| Q4 24 | 42.9% | 12.9% | ||
| Q3 24 | 36.3% | 15.2% | ||
| Q2 24 | 38.3% | 15.4% | ||
| Q1 24 | 37.0% | 13.7% |
| Q4 25 | -130.8% | -4.4% | ||
| Q3 25 | -73.1% | 0.4% | ||
| Q2 25 | 12.0% | -8.2% | ||
| Q1 25 | 7.4% | 3.0% | ||
| Q4 24 | 19.2% | -4.3% | ||
| Q3 24 | 12.7% | 2.7% | ||
| Q2 24 | 6.0% | 2.2% | ||
| Q1 24 | 8.1% | -2.6% |
| Q4 25 | -158.8% | -7.1% | ||
| Q3 25 | -105.0% | -1.7% | ||
| Q2 25 | 6.3% | -10.8% | ||
| Q1 25 | -2.0% | -0.4% | ||
| Q4 24 | -1.3% | -9.7% | ||
| Q3 24 | 6.1% | -2.1% | ||
| Q2 24 | 28.4% | 1.4% | ||
| Q1 24 | -0.3% | -2.5% |
| Q4 25 | $-13.77 | $-0.56 | ||
| Q3 25 | $-4.52 | $-0.14 | ||
| Q2 25 | $0.53 | $-0.92 | ||
| Q1 25 | $-0.12 | $-0.03 | ||
| Q4 24 | $-0.13 | $-0.82 | ||
| Q3 24 | $0.52 | $-0.19 | ||
| Q2 24 | $2.35 | $0.13 | ||
| Q1 24 | $-0.02 | $-0.22 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $584.5M | $429.0M |
| Total DebtLower is stronger | $3.4B | $2.0B |
| Stockholders' EquityBook value | $2.1B | $2.8B |
| Total Assets | $9.7B | $7.0B |
| Debt / EquityLower = less leverage | 1.62× | 0.73× |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $584.5M | $429.0M | ||
| Q3 25 | $497.7M | $468.0M | ||
| Q2 25 | $438.2M | $399.0M | ||
| Q1 25 | $315.3M | $334.0M | ||
| Q4 24 | $357.3M | $340.0M | ||
| Q3 24 | $416.7M | $330.0M | ||
| Q2 24 | $471.5M | $335.0M | ||
| Q1 24 | $417.8M | $552.0M |
| Q4 25 | $3.4B | $2.0B | ||
| Q3 25 | $3.4B | $2.0B | ||
| Q2 25 | $3.4B | $2.0B | ||
| Q1 25 | $3.1B | $2.0B | ||
| Q4 24 | $3.1B | $1.8B | ||
| Q3 24 | $3.1B | $1.9B | ||
| Q2 24 | $3.1B | $1.9B | ||
| Q1 24 | $3.1B | $2.1B |
| Q4 25 | $2.1B | $2.8B | ||
| Q3 25 | $3.8B | $2.8B | ||
| Q2 25 | $4.4B | $2.8B | ||
| Q1 25 | $4.4B | $3.0B | ||
| Q4 24 | $4.5B | $3.0B | ||
| Q3 24 | $4.6B | $3.1B | ||
| Q2 24 | $4.6B | $3.1B | ||
| Q1 24 | $4.3B | $3.2B |
| Q4 25 | $9.7B | $7.0B | ||
| Q3 25 | $12.1B | $7.1B | ||
| Q2 25 | $12.3B | $7.1B | ||
| Q1 25 | $11.8B | $7.2B | ||
| Q4 24 | $11.7B | $7.1B | ||
| Q3 24 | $12.2B | $7.3B | ||
| Q2 24 | $12.1B | $7.3B | ||
| Q1 24 | $12.0B | $7.6B |
| Q4 25 | 1.62× | 0.73× | ||
| Q3 25 | 0.89× | 0.73× | ||
| Q2 25 | 0.76× | 0.72× | ||
| Q1 25 | 0.71× | 0.66× | ||
| Q4 24 | 0.69× | 0.62× | ||
| Q3 24 | 0.68× | 0.60× | ||
| Q2 24 | 0.68× | 0.62× | ||
| Q1 24 | 0.72× | 0.65× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $657.1M | $76.0M |
| Free Cash FlowOCF − Capex | $631.1M | $19.0M |
| FCF MarginFCF / Revenue | 58.3% | 1.4% |
| Capex IntensityCapex / Revenue; lower = less reinvestment burden | 2.4% | 4.2% |
| Cash ConversionOCF / Net Profit; >1× = earnings back up with cash | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-102.5M | $116.0M |
8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.
| Q4 25 | $657.1M | $76.0M | ||
| Q3 25 | $-184.2M | $196.0M | ||
| Q2 25 | $65.9M | $91.0M | ||
| Q1 25 | $-545.0M | $-74.0M | ||
| Q4 24 | $427.9M | $153.0M | ||
| Q3 24 | $159.5M | $129.0M | ||
| Q2 24 | $292.2M | $46.0M | ||
| Q1 24 | $-142.9M | $-65.0M |
| Q4 25 | $631.1M | $19.0M | ||
| Q3 25 | $-207.9M | $153.0M | ||
| Q2 25 | $50.9M | $54.0M | ||
| Q1 25 | $-576.6M | $-110.0M | ||
| Q4 24 | $406.3M | $102.0M | ||
| Q3 24 | $143.8M | $88.0M | ||
| Q2 24 | $282.3M | $-4.0M | ||
| Q1 24 | $-163.6M | $-107.0M |
| Q4 25 | 58.3% | 1.4% | ||
| Q3 25 | -38.3% | 10.5% | ||
| Q2 25 | 4.8% | 3.7% | ||
| Q1 25 | -72.9% | -7.8% | ||
| Q4 24 | 33.2% | 7.0% | ||
| Q3 24 | 13.5% | 5.7% | ||
| Q2 24 | 27.2% | -0.3% | ||
| Q1 24 | -17.8% | -7.3% |
| Q4 25 | 2.4% | 4.2% | ||
| Q3 25 | 4.4% | 2.9% | ||
| Q2 25 | 1.4% | 2.5% | ||
| Q1 25 | 4.0% | 2.6% | ||
| Q4 24 | 1.8% | 3.5% | ||
| Q3 24 | 1.5% | 2.7% | ||
| Q2 24 | 1.0% | 3.2% | ||
| Q1 24 | 2.3% | 2.9% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.45× | — | ||
| Q2 24 | 0.99× | 2.09× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.
Revenue Breakdown by Segment
FMC
| Insecticides | $440.3M | 41% |
| Herbicides | $378.8M | 35% |
| Fungicides | $140.4M | 13% |
| Plant Health | $65.6M | 6% |
| Other | $45.0M | 4% |
HUN
| Diversified | $897.0M | 66% |
| Specialty | $231.0M | 17% |
| Performance Products | $113.0M | 8% |
| Advanced Materials | $61.0M | 5% |
| Related Party Customers | $19.0M | 1% |
| Other | $12.0M | 1% |
